The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kck Ltd. since 2017.
This trader's CIK number is 1657662.
At the time of last reporting, Kck Ltd. was the 10% Owner of Neuropace Inc. (stock ticker symbol NPCE).
Also see all insider trading activities at Neuropace Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ALRN | 200,000 | $3,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NPCE | 0 | $0 | 5,270,845 | $49,545,943 | 0 | $0 |
| 2024 | NPCE | 0 | $0 | 322,928 | $1,878,154 | 0 | $0 |
| 2023 | NPCE | 0 | $0 | 27,338 | $240,988 | 0 | $0 |
1. Aileron Therapeutics, Inc. (ALRN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-05 | ALRN | Buy | 200,000 | 15.00 | 3,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-20 | NPCE | Sale | 5,270,845 | 9.40 | 49,545,943 |
| 2024-10-25 | NPCE | Sale | 223,991 | 5.45 | 1,220,974 |
| 2024-10-23 | NPCE | Sale | 147 | 6.02 | 884 |
| 2024-10-22 | NPCE | Sale | 4,082 | 6.09 | 24,855 |
| 2024-10-21 | NPCE | Sale | 3,720 | 6.10 | 22,677 |
| 2024-10-18 | NPCE | Sale | 4,878 | 6.29 | 30,692 |
| 2024-10-17 | NPCE | Sale | 3,294 | 6.28 | 20,686 |
| 2024-10-16 | NPCE | Sale | 6,900 | 6.57 | 45,339 |
| 2024-10-15 | NPCE | Sale | 4,017 | 6.50 | 26,098 |
| 2024-10-14 | NPCE | Sale | 4,031 | 6.54 | 26,358 |
| 2024-10-09 | NPCE | Sale | 3,123 | 6.11 | 19,065 |
| 2024-10-11 | NPCE | Sale | 2,572 | 6.34 | 16,319 |
| 2024-10-08 | NPCE | Sale | 6,000 | 6.42 | 38,550 |
| 2024-10-10 | NPCE | Sale | 2,504 | 6.12 | 15,316 |
| 2024-10-07 | NPCE | Sale | 4,910 | 6.66 | 32,685 |
| 2024-10-04 | NPCE | Sale | 5,757 | 6.92 | 39,832 |
| 2024-10-03 | NPCE | Sale | 3,318 | 6.97 | 23,116 |
| 2024-09-20 | NPCE | Sale | 765 | 7.50 | 5,737 |
| 2024-08-30 | NPCE | Sale | 4,314 | 7.76 | 33,476 |
| 2024-09-13 | NPCE | Sale | 1,993 | 7.59 | 15,126 |
| 2024-09-06 | NPCE | Sale | 11 | 7.50 | 82 |
| 2024-09-04 | NPCE | Sale | 14 | 7.50 | 105 |
| 2024-09-03 | NPCE | Sale | 2,093 | 7.60 | 15,906 |
| 2024-09-30 | NPCE | Sale | 4,749 | 6.73 | 31,960 |
| 2024-09-27 | NPCE | Sale | 5,059 | 6.63 | 33,541 |
| 2024-09-26 | NPCE | Sale | 5,821 | 6.62 | 38,535 |
| 2024-09-25 | NPCE | Sale | 5,858 | 6.60 | 38,662 |
| 2024-10-02 | NPCE | Sale | 3,843 | 6.87 | 26,401 |
| 2024-09-23 | NPCE | Sale | 282 | 7.54 | 2,126 |
| 2024-10-01 | NPCE | Sale | 4,882 | 6.77 | 33,051 |
| 2023-12-01 | NPCE | Sale | 3,241 | 8.73 | 28,293 |
| 2023-11-30 | NPCE | Sale | 7,282 | 8.84 | 64,372 |
| 2023-11-29 | NPCE | Sale | 5,644 | 8.72 | 49,215 |
| 2023-11-27 | NPCE | Sale | 6,490 | 8.96 | 58,150 |
| 2023-11-28 | NPCE | Sale | 4,681 | 8.75 | 40,958 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kck Ltd. (10% Owner of Neuropace Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.